Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles

Virology

Volumn 476, Issue , 2015, Pages 11-18

  Bucafusco, Danilo ^a,b   Di Giacomo, Sebastián ^a   Pega, Juan ^a,b   Schammas, Juan Manuel ^a   Cardoso, Nancy ^a   Capozzo, Alejandra Victoria ^a,b   Perez Filgueira, Mariano ^a,b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Capsid integrity; Cattle; FMD vaccines; FMDV; IFN

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; GAMMA INTERFERON; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CATTLE DISEASE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INTERFERON PRODUCTION; NONHUMAN; T LYMPHOCYTE; VACCINATION; VIRUS PARTICLE; ANIMAL; BOVINAE; CATTLE DISEASES; CHEMISTRY; CLASSIFICATION; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; VIROLOGY;

ANIMALIA; BOS; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

ANIMALS; CATTLE; CATTLE DISEASES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; INTERFERON-GAMMA; VACCINATION; VIRAL VACCINES;

EID: 84916920262     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.11.023     Document Type: Article

References (48)

1. Alexandersen S., Mowat N. Foot-and-mouth disease: host range and pathogenesis. Curr. Top. Microbiol. Immunol. 2005, 288:9-42.
2. Alexandersen S., Zhang Z., Donaldson A.I., Garland A.J. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Pathol. 2003, 129:1-36.
3. Anderson E.C., Doughty W.J., Anderson J. The effect of repeated vaccination in an enzootic foot-and-mouth disease area on the incidence of virus carrier cattle. J. Hyg. (Lond) 1974, 73:229-235.
4. Barnett P.V., Keel P., Reid S., Armstrong R.M., Statham R.J., Voyce C., Aggarwal N., Cox S.J. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. Vaccine 2004, 22:1221-1232.
5. Barnett P.V., Statham R.J., Vosloo W., Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 2003, 21:3240-3248.
6. Barteling S.J., Meloen R.H. A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV). Arch. Gesamte. Virusforsch. 1974, 45:362-364.
7. Becker Y. Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view. Virus Genes. 1994, 8:199-214.
8. Brown W.C., Zhao S., Woods V.M., Tripp C.A., Tetzlaff C.L., Heussler V.T., Dobbelaere D.A., Rice-Ficht A.C. Identification of two Th1 cell epitopes on the Babesia bovis-encoded 77-kilodalton merozoite protein (Bb-1) by use of truncated recombinant fusion proteins. Infect. Immun. 1993, 61:236-244.
9. Carr B.V., Lefevre E.A., Windsor M.A., Inghese C., Gubbins S., Prentice H., Juleff N.D., Charleston B. CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. J. Gen. Virol. 2013, 94:97-107.
10. Cartwright B., Chapman W.G., Brown F. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. J. Gen. Virol. 1980, 50:369-375.
11. Cartwright B., Morrell D.J., Brown F. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. J. Gen. Virol. 1982, 63:375-381.
12. Collen T., Baron J., Childerstone A., Corteyn A., Doel T.R., Flint M., Garcia-Valcarcel M., Parkhouse R.M., Ryan M.D. Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res. 1998, 56:125-133.
13. Collen T., Doel T.R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Virol. 1990, 71(Pt 2):309-315.
14. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J., Barnett P.V. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 2006, 24:3184-3190.
15. Diaz-San Segundo F., Moraes M.P., de Los Santos T., Dias C.C., Grubman M.J. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J. Virol. 2010, 84:2063-2077.
16. Doel T.R. FMD vaccines. Virus Res. 2003, 91:81-99.
17. Doel T.R., Baccarini P.J. Thermal stability of foot-and-mouth disease virus. Arch. Virol. 1981, 70:21-32.
18. Doel T.R., Chong W.K. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch. Virol. 1982, 73:185-191.
19. Goris N., Willems T., Diev V.I., Merkelbach-Peters P., Vanbinst T., Van der Stede Y., Kraft H.P., Zakharov V.M., Borisov V.V., Nauwynck H.J., Haas B., De Clercq K. Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative. Vaccine 2008, 26:3870-3879.
20. Gormley E., Doyle M.B., Fitzsimons T., McGill K., Collins J.D. Diagnosis of Mycobacterium bovis infection in cattle by use of the gamma-interferon (Bovigam) assay. Vet. Microbiol. 2006, 112:171-179.
21. Juleff N., Windsor M., Lefevre E.A., Gubbins S., Hamblin P., Reid E., McLaughlin K., Beverley P.C., Morrison I.W., Charleston B. Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naive cattle. J. Virol. 2009, 83:3626-3636.
22. King A., Lefkowitz E., Adams M.J., Carstens E.B. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses 2011, Elsevier. ed.
23. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91:65-80.
24. Lightbody K.A., Girvin R.M., Pollock D.A., Mackie D.P., Neill S.D., Pollock J.M. Recognition of a common mycobacterial T-cell epitope in MPB59 of mycobacterium bovis. Immunology 1998, 93:314-322.
25. Mackay D., Parida S., Paton D., Anderson J. Making a vaccinate-to-live policy a reality in foot-and-mouth disease. Dev. Biol. (Basel) 2004, 119:261-266.
26. Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., Iglesias M., D'Aloia R., Mattion N. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine 2008, 26:6577-6586.
27. Moraes M.P., de Los Santos T., Koster M., Turecek T., Wang H., Andreyev V.G., Grubman M.J. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 2007, 81:7124-7135.
28. Muroga N., Hayama Y., Yamamoto T., Kurogi A., Tsuda T., Tsutsui T. The foot-and-mouth disease epidemic in Japan. J. Vet. Med. Sci. 2012, 74(4):399-404. . (Epub 2011 Nov 11).
29. Oh Y., Fleming L., Statham B., Hamblin P., Barnett P., Paton D.J., Park J.H., Joo Y.S., Parida S. Interferon-gamma induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection. PloS One 2012, 7:e44365.
30. Orsel K., Dekker A., Bouma A., Stegeman J.A., Jong M.C.M.d. Vaccination against foot and mouth disease reduces virus transmission in groups of calves. Vaccine 2005, 23:4887-4894.
31. Parida S., Oh Y., Reid S.M., Cox S.J., Statham R.J., Mahapatra M., Anderson J., Barnett P.V., Charleston B., Paton D.J. Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 2006, 24:964-969.
32. Pay T.W., Hingley P.J. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 1987, 5:60-64.
33. Pay T.W., Hingley P.J. A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle. Vaccine 1992, 10:707-713.
34. Pega J., Bucafusco D., Di Giacomo S., Schammas J.M., Malacari D., Capozzo A.V., Arzt J., Perez-Beascoechea C., Maradei E., Rodriguez L.L., Borca M.V., Perez-Filgueira M. Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle. J. Virol. 2013, 87:2489-2495.
35. Perez A.M., Ward M.P., Carpenter T.E. Control of a foot-and-mouth disease epidemic in Argentina. Prev. Vet. Med. 2004, 65:217-226.
36. Perry B.D., Rich K.M. Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control. Vet. Rec. 2007, 160:238-241.
37. Poulin M.C., Christianson W.T. On-farm eradication of foot-and-mouth disease as an alternative to mass culling. Vet. Rec. 2006, 158:467-472.
38. Rao M.G., Butchaiah G., Sen A.K. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1. Vet. Microbiol. 1994, 39:135-143.
39. Saiz J.C., Rodriguez A., Gonzalez M., Alonso F., Sobrino F. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J. Gen. Virol. 1992, 73(Pt 10):2601-2607.
40. Saraiva V., Darsie G. The use of vaccines in South American foot-and-mouth disease eradication programmes. Dev. Biol. (Basel) 2004, 119:33-40.
41. Schiller I., Waters W.R., Vordermeier H.M., Nonnecke B., Welsh M., Keck N., Whelan A., Sigafoose T., Stamm C., Palmer M., Thacker T., Hardegger R., Marg-Haufe B., Raeber A., Oesch B. Optimization of a whole-blood gamma interferon assay for detection of mycobacterium bovis-infected cattle. Clin. Vaccine Immun.: CVI 2009, 16:1196-1202.
42. Sing T., Sander O., Beerenwinkel N., Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21:3940-3941.
43. Thompson D., Muriel P., Russell D., Osborne P., Bromley A., Rowland M., Creigh-Tyte S., Brown C. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev. Sci. Tech. 2002, 21:675-687.
44. Toka F.N., Kenney M.A., Golde W.T. Rapid and transient activation of gammadelta T cells to IFN-gamma production, NK cell-like killing, and antigen processing during acute virus infection. J. Immun. 2011, 186:4853-4861.
45. Wood P.R., Rothel J.S. In vitro immunodiagnostic assays for bovine tuberculosis. Vet. Microbiol. 1994, 40:125-135.
46. Woolums A.R., Siger L., Johnson S., Gallo G., Conlon J. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production. Vaccine 2003, 21:1158-1164.
47. Yang P.C., Chu R.M., Chung W.B., Sung H.T. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet. Rec. 1999, 145:731-734.
48. Zhang Z.D., Hutching G., Kitching P., Alexandersen S. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch. Virol. 2002, 147:2157-2167.